(4151) – Management Comments
-
MEI Pharma (MEIP), Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
-
Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO Oncology (AVEO)
-
-
Back to 4151 Stock Lookup